News from auxilium pharmaceuticals, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Sep 18, 2014, 07:00 ET

Auxilium Pharmaceuticals, Inc. Presents XIAFLEX (CCH) Data From MULTICORD And Retreatment Studies At The ASSH Annual Meeting

 Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, today announced the first presentation of positive...

Sep 18, 2014, 06:00 ET

VIVUS And Auxilium Announce FDA Approval Of STENDRA sNDA; STENDRA Now First And Only Oral Erectile Dysfunction Treatment Approved To Be Taken Approximately 15 Minutes Before Sexual Activity

VIVUS, Inc. (Nasdaq: VVUS) and Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL) today announced that the U.S. Food and Drug Administration (FDA) has...

Sep 17, 2014, 07:00 ET
Auxilium Offer Letter (PRNewsFoto/Auxilium Pharmaceuticals, Inc.)

Auxilium Responds To Unsolicited Proposal From Endo International

 Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, today confirmed that Auxilium has received an...

Sep 09, 2014, 17:00 ET

Auxilium Pharmaceuticals, Inc. Announces Corporate Restructuring Designed To Streamline Operations, Maximize Cash Flow And Drive Sustainable Earnings Growth

 Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, today announced steps it is taking to reduce its costs...

Aug 28, 2014, 06:00 ET

Auxilium Pharmaceuticals, Inc. To Present CCH Data For Concurrent Treatment Of Multiple Dupuytren's Cords At ASSH Annual Meeting

Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, today announced that data from trials evaluating the use of...

Aug 27, 2014, 06:00 ET

Auxilium Pharmaceuticals, Inc. To Present At The Morgan Stanley Healthcare Conference

 Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a fully integrated specialty biopharmaceutical company, today announced that certain members of...

Aug 21, 2014, 07:30 ET

Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite

 Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, today announced positive results from a randomized,...

Aug 11, 2014, 06:00 ET

Auxilium Pharmaceuticals, Inc. Appoints Andrew Saik Chief Financial Officer

 Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a fully integrated specialty biopharmaceutical company, announced that Andrew Saik will be...

Aug 07, 2014, 06:00 ET

Auxilium Pharmaceuticals, Inc. Announces Second Quarter 2014 Financial Results

 Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a fully integrated specialty biopharmaceutical company, today announced financial results for...

Jul 31, 2014, 16:30 ET

Auxilium Pharmaceuticals, Inc. To Announce Second Quarter 2014 Results On August 7, 2014

 Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a fully integrated specialty biopharmaceutical company, today announced that the Company will...

Jul 31, 2014, 06:00 ET

Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan

Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, today announced that the Company will receive a $10 million...

Jun 26, 2014, 07:00 ET

Auxilium Pharmaceuticals to Merge with Canadian Biotechnology Company QLT

 Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a fully integrated specialty biopharmaceutical company, and QLT Inc. (NASDAQ: QLTI) (TSX: QLT),...

Jun 25, 2014, 08:00 ET

Sobi files for EU approval of Xiapex for Peyronies disease

 Swedish Orphan Biovitrum AB (publ) (Sobi) and Auxilium Pharmaceuticals, Inc. today announced that Sobi has filed for an extension of the label...

Jun 11, 2014, 07:00 ET

Auxilium Pharmaceuticals, Inc. Announces Launch Of Authorized Generic Version Of Testim (Testosterone Gel)

 Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a fully integrated specialty biopharmaceutical company, today announced that it has partnered...

Jun 02, 2014, 16:30 ET

Auxilium Pharmaceuticals, Inc. Announces Departure of Chief Financial Officer

Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a fully integrated specialty biopharmaceutical company, today announced that James E. Fickenscher,...

May 30, 2014, 09:00 ET

Auxilium Pharmaceuticals, Inc. To Present At The Jefferies Healthcare Conference

 Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a fully integrated specialty biopharmaceutical company, today announced that certain members of...

May 19, 2014, 07:00 ET

Auxilium Pharmaceuticals, Inc. Presents New Analyses Of XIAFLEX Peyronie's Disease Data At Urology Meeting

Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a fully integrated specialty biopharmaceutical company, today announced that new analyses of data...

May 12, 2014, 06:00 ET

Auxilium Pharmaceuticals, Inc. To Present At The UBS Healthcare Conference

 Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a fully integrated specialty biopharmaceutical company, today announced that certain members of...

May 07, 2014, 06:00 ET

Auxilium Pharmaceuticals, Inc. To Present At The Bank Of America Merrill Lynch Healthcare Conference

 Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a fully integrated specialty biopharmaceutical company, today announced that certain members of...

May 05, 2014, 06:00 ET

Auxilium Pharmaceuticals, Inc. Announces First Quarter 2014 Financial Results

 Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a fully integrated specialty biopharmaceutical company, today announced financial results for...